Advances in epilepsy associated with 16p11.2 microdeletion syndrome
Abstract Background 16p11.2 microdeletion syndrome is a genetic disorder with a population prevalence of approximately 2.84.3 per 100,000 individuals. Epilepsy is one of its core symptoms, significantly impacting neurodevelopment and quality of life. Current treatment strategies are shifting from em...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley
2025-10-01
|
| Sarja: | Clinical and Translational Discovery |
| Aiheet: | |
| Linkit: | https://doi.org/10.1002/ctd2.70088 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|